| 000 | 01506 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518091120.0 | ||
| 264 | 0 | _c20200403 | |
| 008 | 202004s 0 0 chi d | ||
| 022 | _a0578-1426 | ||
| 024 | 7 |
_a10.3760/cma.j.issn.0578-1426.2020.03.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPei, R Z | |
| 245 | 0 | 0 |
_a[Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia]. _h[electronic resource] |
| 260 |
_bZhonghua nei ke za zhi _cMar 2020 |
||
| 300 |
_a213-217 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntibiotic Prophylaxis |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInduction Chemotherapy |
| 650 | 0 | 4 |
_aInvasive Fungal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aLu, Y | |
| 700 | 1 | _aZhang, P S | |
| 700 | 1 | _aLiu, X H | |
| 700 | 1 | _aChen, D | |
| 700 | 1 | _aDu, X H | |
| 700 | 1 | _aSha, K Y | |
| 700 | 1 | _aLi, S Y | |
| 700 | 1 | _aCao, J J | |
| 700 | 1 | _aChen, L G | |
| 700 | 1 | _aZhuang, X X | |
| 700 | 1 | _aTang, S H | |
| 773 | 0 |
_tZhonghua nei ke za zhi _gvol. 59 _gno. 3 _gp. 213-217 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3760/cma.j.issn.0578-1426.2020.03.008 _zAvailable from publisher's website |
| 999 |
_c30717354 _d30717354 |
||